Misplaced Pages

Bladder tumor antigen: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 21:02, 28 December 2024 editGraham Beards (talk | contribs)Autopatrolled, Administrators35,532 edits bot !!← Previous edit Revision as of 00:38, 29 December 2024 edit undoJosve05a (talk | contribs)Autopatrolled, Extended confirmed users, New page reviewers, Pending changes reviewers, Rollbackers155,019 editsm clean up, added uncategorised tagTag: AWBNext edit →
Line 1: Line 1:
{{Short description|Laboratory test for bladder cancer}} {{Short description|Laboratory test for bladder cancer}}
The '''bladder tumour antigen''' (BTA) test is used in the detection of ]. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the ''amount'' of the antigen is measured. <ref name="pmid35950042">{{cite journal |vauthors=Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K |title=Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis |journal=BJUI Compass |volume=3 |issue=5 |pages=334–343 |date=September 2022 |pmid=35950042 |pmc=9349596 |doi=10.1002/bco2.147 |url=}}</ref><ref name="pmid24940462">{{cite journal |vauthors=Guo A, Wang X, Gao L, Shi J, Sun C, Wan Z |title=Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis |journal=Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada |volume=8 |issue=5-6 |pages=E347–52 |date=May 2014 |pmid=24940462 |pmc=4039599 |doi=10.5489/cuaj.1668 |url=}}</ref> The '''bladder tumour antigen''' (BTA) test is used in the detection of ]. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the ''amount'' of the antigen is measured.<ref name="pmid35950042">{{cite journal |vauthors=Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K |title=Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis |journal=BJUI Compass |volume=3 |issue=5 |pages=334–343 |date=September 2022 |pmid=35950042 |pmc=9349596 |doi=10.1002/bco2.147 |url=}}</ref><ref name="pmid24940462">{{cite journal |vauthors=Guo A, Wang X, Gao L, Shi J, Sun C, Wan Z |title=Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis |journal=Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada |volume=8 |issue=5-6 |pages=E347–52 |date=May 2014 |pmid=24940462 |pmc=4039599 |doi=10.5489/cuaj.1668 |url=}}</ref>


==References== ==References==


{{reflist}} {{reflist}}

{{Uncategorized|date=December 2024}}

Revision as of 00:38, 29 December 2024

Laboratory test for bladder cancer

The bladder tumour antigen (BTA) test is used in the detection of bladder cancer. It works by detecting raised levels of complement factor H‐related protein (CFHrp), which is produced by cancer cells, in urine. The test can be qualitative, in which just the presence of the antigen is detected or quantitative, in which the amount of the antigen is measured.

References

  1. Soputro NA, Gracias DN, Dias BH, Nzenza T, O'Connell H, Sethi K (September 2022). "Utility of urinary biomarkers in primary haematuria: Systematic review and meta-analysis". BJUI Compass. 3 (5): 334–343. doi:10.1002/bco2.147. PMC 9349596. PMID 35950042.
  2. Guo A, Wang X, Gao L, Shi J, Sun C, Wan Z (May 2014). "Bladder tumour antigen (BTA stat) test compared to the urine cytology in the diagnosis of bladder cancer: A meta-analysis". Canadian Urological Association Journal = Journal De l'Association Des Urologues Du Canada. 8 (5–6): E347–52. doi:10.5489/cuaj.1668. PMC 4039599. PMID 24940462.
This article has not been added to any content categories. Please help out by adding categories to it so that it can be listed with similar articles. (December 2024)
Category: